LexDanaLexDanabeta
Inventor

Monika SEMMRICH

Inventor
SE

Overview

4→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
C12NMicroorganisms or enzymes7%
Y02ATechnologies for adaptation to climate change7%
PatentTitleYear
12,441,805Antagonistic anti-TNFR2 antibodies202512,291,569Antibodies and nucleotide sequences, and uses thereof202512,139,547Agonistic anti TNFR2 antibody molecules202411,447,549Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to BIOINVENT INT AB (4)· patent assignee history
2022Patents assigned to CANCER RESEARCH TECH LTD (1)· patent assignee history
2022–2025Based in SE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOINVENT INT AB42022–2025
CANCER RESEARCH TECH LTD12022
Locations
LocationPatentsSpan
SE42022–2025